Risk Management And Error Prevention - NAPLEX

Clarify with the prescriber before dispensing or administering. Seeking clarification prevents misinterpretation that could lead to harmful medication administration or dispensing.

Noxious, unintended response at normal doses. This definition highlights unintended effects despite proper dosing, emphasizing pharmacovigilance in patient safety.

Learning/accountability with a nonpunitive response to human error. It promotes error reporting for learning while ensuring accountability for intentional risks, fostering a safer environment.

Preventable event causing or risking inappropriate medication use. This focuses on avoidable failures in the medication use process that may lead to harm, promoting error prevention strategies.

Error occurred but did not reach the patient. Intercepted errors allow for system improvements without patient impact, serving as valuable learning opportunities in safety practices.

U (use “units” instead). Avoiding this abbreviation prevents misreading that could result in dosing errors or unit confusion.

Unexpected death or serious harm requiring immediate investigation. Such events indicate severe safety lapses, mandating thorough review to prevent future occurrences in healthcare settings.

High-alert medications. These drugs warrant enhanced protocols due to their potential for severe consequences from even minor errors.

Trailing zero (write 1 mg, not 1.0 mg). Eliminating trailing zeros avoids tenfold dosage misreads if the decimal point is obscured or ignored.

Use tall man lettering plus segregation and independent double-checks. Combining visual differentiation, physical separation, and verification reduces selection errors in handling similar medications.

Identify system causes and implement actions to prevent recurrence. RCA uncovers underlying systemic issues to develop preventive measures, shifting focus from blame to process enhancement.

Proactively identify process failures and mitigate risk before harm. FMEA anticipates vulnerabilities in processes, enabling risk reduction strategies prior to any adverse outcomes.

System-based improvement (focus on process design and safeguards). Modern safety prioritizes redesigning processes and adding safeguards to minimize human error rather than punishing individuals.

Write/enter then read back and verify (read-back with confirmation). This method ensures accuracy by confirming the order through repetition and validation, minimizing communication mishaps.

Injury resulting from medication use (includes errors and ADRs). ADEs encompass all medication-related injuries, whether from preventable errors or inherent drug risks, to guide comprehensive safety measures.

Match patient, drug, dose, route, and directions to the prescription. This aligns with the five rights principle, ensuring all elements match to prevent dispensing inaccuracies.

Verify weight/units and clarify dose with prescriber before filling. Pediatric doses require weight verification to avoid overdoses, necessitating prescriber confirmation for safety.

Hold dispensing and contact prescriber to change therapy. Amoxicillin shares penicillin's structure, risking severe allergic reactions, so prescriber involvement is essential for alternative therapy.

Lack of a leading zero (write 0.5 mg, not .5 mg). Including leading zeros ensures decimal visibility, preventing misinterpretation of sub-unit doses as whole numbers.

Stop and reconcile; correct SIG to match the verified prescription. Correcting discrepancies ensures instructions match the prescription, preventing potential overdosing or underdosing errors.

Remove from floor stock; use premixed/standard concentrations when possible. Restricting access to concentrates prevents fatal undiluted administration, favoring safer standardized preparations.

Contact patient immediately, arrange replacement, and document/report per policy. Immediate intervention averts potential harm, with documentation supporting error analysis and policy compliance.

Do not substitute; contact prescriber because release form changes therapy. Formulation changes affect drug release and efficacy, requiring prescriber approval to maintain therapeutic integrity.

Request at least two identifiers (for example name and DOB). Using multiple identifiers provides reliable verification, reducing risks of misidentification compared to leading questions.